FibroBiologics, Inc. Common Stock (FBLG)
Healthcare
Biotechnology
0.79 $
+12.9%
vs. previous close
Closing price · As of: 3. Aug 2026
FibroBiologics, Inc. Common Stock (FBLG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 7.9 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13 | 12 | 11 | 8.9 | 10 | 16 | 11 | 14 | 8.7 | 9.6 | 5.9 | 7.9 | |
| 11 | 9.2 | 8.9 | 6.5 | 8.2 | 14 | 9.3 | 10 | 5.2 | 6.3 | 2.9 | 5.9 | |
| 11 | 9.2 | 8.2 | 6.0 | 7.8 | 14 | 8.7 | 8.8 | 4.9 | 4.9 | 1.5 | 3.5 | |
| 11 | 9.2 | 8.2 | 6.0 | 7.8 | 14 | 8.7 | 8.8 | 4.9 | 4.9 | 1.5 | 3.5 | |
| 2.8 | 11 | 15 | 11 | 7.7 | 14 | 9.1 | 13 | 8.6 | 3.5 | 3.3 | 3.3 | |
| 1.3 | 9.2 | 14 | 10 | 6.7 | 13 | 8.2 | 11 | 6.7 | 1.8 | 1.8 | 2.2 | |
| 0.7 | 0.7 | 0.8 | 0.7 | 0.5 | 9.6 | 6.3 | 8.7 | 5.2 | 0.7 | 1.0 | 0.3 | |
| 0.8 | 1.4 | 0.8 | 1.2 | 1.2 | 2.7 | 1.4 | 1.8 | 1.1 | 0.9 | 0.9 | – | |
| 11 | 1.3 | -3.9 | -2.4 | 2.7 | 2.7 | 2.4 | 0.9 | 0.1 | 6.2 | 2.6 | 4.6 | |
| -15 | -24 | -33 | -32 | -32 | -36 | -40 | -45 | -51 | -54 | -59 | -63 | |
| 1.6 | 1.6 | 1.6 | 1.6 | 1.7 | 1.7 | 1.8 | 1.9 | 2.2 | 2.2 | 2.2 | 6.3 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.